St. Boniface Research welcomes Dr. Ross Feldman

A reception was held at the St. Boniface Hospital Albrechtsen Research Centre this afternoon to welcome Dr. Ross Feldman, who joins both the Research Centre as a member of the Institute of Cardiovascular Sciences, and the WRHA as Medical Director of the Cardiac Sciences Program. Dr. Feldman comes to Winnipeg from the Memorial University of Newfoundland where was Professor of Medicine and Chair, Discipline of Medicine.

Dr. Feldman received his medical degree from Queen’s University, his training in Internal Medicine at University of Toronto and a fellowship in Clinical Pharmacology from Vanderbilt University. Dr. Feldman has also held teaching positions at the University of Iowa, College of Medicine in Iowa City and the University of Western Ontario and Chair, Division of Clinical Pharmacology in the Department of Medicine at the University of Western Ontario. As well, he also served as Scientific Director of the Robarts Research Institute at Western.

Dr. Feldman’s research program will focus on Women’s Health; specifically, the development of innovative strategies in the primary prevention of cardiovascular disease. He is the author of more than 200 articles in the fields of cell signaling, adrenergic pharmacology and management of risks factors important in the development of heart disease and strokes.

Dr. Feldman has held leadership roles in a number of scientific and professional organizations in the disciplines of medicine and pharmacology including Vice-President of the American Society of Clinical Pharmacology and Therapeutics and Chair of the Clinical Pharmacology Division of the American Society of Pharmacology and Experimental Therapeutics. He has served as Governor of the Ontario Chapter, American College of Physicians, Chair of the Scientific Review Committee of the Heart and Stroke Foundation of Canada, chair of the Research Committee and a member of the Board of Directors of the Heart and Stroke Foundation of Ontario and the past Governor of the Ontario Chapter, American College of Physicians. He was founding president of both the Canadian Hypertension Education Program (CHEP) as well as its successor, Hypertension Canada, where he continues to be active at the public policy level in improving hypertension management and control rates in Canada. He is currently an Associate Editor of both the Canadian Journal of Cardiology and Canadian Journal of Physiology and Pharmacology and past Editor-in-Chief of Pharmacological Reviews.

Throughout his career, Dr. Feldman has earned numerous awards and scholarships; he is the recipient of a Career Investigator Award from the Heart and Stroke Foundation of Ontario, a George Morris Piersol Research and Teaching Scholarship from the American College of Physicians, the Burroughs-Wellcome Clinical Pharmacology Award, the Senior Investigator Award from the Canadian Society for Clinical Pharmacology as well as the Distinguished Service/Research Award of the Canadian Hypertension Society. He received the George Fodor Award for outstanding contributions to the prevention and control of hypertension (2010) and was awarded the Ken Brown Research Award from our own Institute of Cardiovascular Sciences.